Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Ginkgo Bioworks Holdings, Inc. | d549678d8k.htm |
Exhibit 99.1
SOARING EAGLE ACQUISITION CORP.
BALANCE SHEET
| February 26, 2021 | Pro Forma Adjustments |
As Adjusted | ||||||||||
| (As filed) | (Unaudited) | (Unaudited) | ||||||||||
| ASSETS: |
|
|||||||||||
| Current asset: |
||||||||||||
| Cash |
$ | 3,000,000 | $ | — | $ | 3,000,000 | ||||||
|
|
|
|
|
|
|
|||||||
| Total current assets |
3,000,000 | — | 3,000,000 | |||||||||
| Cash held in Trust Account |
1,725,000,000 | — | 1,725,000,000 | |||||||||
|
|
|
|
|
|
|
|||||||
| Total assets |
$ | 1,728,000,000 | $ | — | $ | 1,728,000,000 | ||||||
|
|
|
|
|
|
|
|||||||
| LIABILITIES AND SHAREHOLDER’S EQUITY: |
|
|||||||||||
| Current liabilities: |
||||||||||||
| Accounts payable and accrued offering costs |
$ | 784,260 | $ | — | $ | 784,260 | ||||||
| Promissory Note - Related Party |
300,000 | — | 300,000 | |||||||||
| Advance from Sponsor |
156,333 | — | 156,333 | |||||||||
|
|
|
|
|
|
|
|||||||
| Total current liabilities |
1,240,593 | — | 1,240,593 | |||||||||
| Derivative warrant liabilities |
— | 107,692,500 | 107,692,500 | |||||||||
| Deferred underwriting compensation |
60,375,000 | — | 60,375,000 | |||||||||
|
|
|
|
|
|
|
|||||||
| Total liabilities |
61,615,593 | 107,692,500 | 156,600,593 | |||||||||
| Class A ordinary shares subject to possible redemptions; 166,138,440 and 155,369,190 shares at $10 per share, actual and adjusted, respectively |
1,661,384,400 | (107,692,500 | ) | 1,553,691,900 | ||||||||
| Commitments and contingencies |
||||||||||||
| Shareholders’ equity: |
||||||||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding |
— | — | — | |||||||||
| Class A ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 6,361,560 and 17,130,810 shares issued and outstanding (excluding 166,138,440 155,369,190 shares subject to possible redemption), actual and adjusted, respectively |
636 | 1,077 | 1,713 | |||||||||
| Class B ordinary shares, $0.0001 par value; 80,000,000 shares authorized; 43,125,000 shares issued and outstanding |
4,312 | — | 4,312 | |||||||||
| Additional paid-in capital |
5,000,059 | 13,336,770 | 18,336,829 | |||||||||
| Accumulated deficit |
(5,000 | ) | (13,337,847 | ) | (13,342,847 | ) | ||||||
|
|
|
|
|
|
|
|||||||
| Total shareholders’ equity |
5,000,007 | — | 5,000,007 | |||||||||
|
|
|
|
|
|
|
|||||||
| Total liabilities and shareholders’ equity |
$ | 1,728,000,000 | $ | — | $ | 1,728,000,000 | ||||||
|
|
|
|
|
|
|
|||||||